| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000007546 |
| Receipt No. | R000008913 |
| Official scientific title of the study | Observational study for pulmonary nontuberculous mycobacterial infection and non-cystic fibrosis bronchiectasis. |
| Date of disclosure of the study information | 2012/03/23 |
| Last modified on | 2019/02/09 (Ver. 15) |
| Basic information | ||
| Official scientific title of the study | Observational study for pulmonary nontuberculous mycobacterial infection and non-cystic fibrosis bronchiectasis. | |
| Title of the study (Brief title) | Observational study for pulmonary nontuberculous mycobacterial infection and non-cystic fibrosis bronchiectasis. | |
| Region |
|
|
| Condition | |||
| Condition | Pulmonary nontuberculous mycobacterial disease and non-cystic fibrosis bronchiectasis | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To investigate the factors associated with occurrence and prognosis of the patients with pulmonary nontuberculous mycobacterial cases and non-cystic fibrosis bronchiectasis in Keio university. |
| Basic objectives2 | Others |
| Basic objectives -Others | To investigate the factors associated with occurrence and prognosis of the patients with pulmonary nontuberculous mycobacterial cases and non-cystic fibrosis bronchiectasis in Keio university. |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | The factors associated with occurrence and prognosis of patients with pulmonary nontuberculous mycobacterial diseases and non-cystic fibrosis bronchiectasis. Prognosis included death, exacerbation, and the changes of health-related quality of life and images. |
| Key secondary outcomes | Nothing |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who diagnosed or suspected with pulmonary nontuberculous mycobacterial disease(PNTMD) or bronchiectasis with informed consent.
PNTMD was diagnosed according to ATS/IDSA 2007 guideline (AJRCCM. 2007 Feb 15;175(4):367-416.). Patients with bronchicectasis was included according to EMBARC registory (ERJ Open Res. 2016 Jan 20;2(1). pii: 00081-2015.) and BRR (Chest. 2017 May;151(5):982-992.). |
|||
| Key exclusion criteria | Patients who don't agree with this study.
As for the diagnosis with bronchiectasis: Asymptomatic patients; Traction bronchiectasis due to interstitial lung disease; History of lung or heart trasplantation. |
|||
| Target sample size | 2700 | |||
| Research contact person | |
| Name of lead principal investigator | Naoki Hasegawa |
| Organization | Keio University Hospital |
| Division name | Center for Infectious Diseases and Infection Control, |
| Address | 35, Shinanomachi, Shinjuku-ku, Tokyo, 162-8582, Japan |
| TEL | 03-3353-3710 |
| n-hasegawa@z8.keio.jp | |
| Public contact | |
| Name of contact person | Takanori Asakura |
| Organization | Keio University Hospital |
| Division name | Division of Pulmonary Medicine, Department of Medicine |
| Address | 35, Shinanomachi, Shinjuku-ku, Tokyo, 162-8582, Japan |
| TEL | 03-3353-1211 |
| Homepage URL | |
| takanori.asakura@gmail.com | |
| Sponsor | |
| Institute | Keio University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | None |
| Other related organizations | |
| Co-sponsor | National institute of infectious disease |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 慶應義塾大学病院(東京都)、結核予防会複十字病院(東京都)、国立病院機構東京医療センター(東京都)、国立病院機構松江医療センター(島根県)、福岡大学病院(福岡)、神戸市立医療センター中央市民病院(神戸)、国立病院機構刀根山病院(大阪)、国立病院機構東名古屋病院(名古屋)、永寿総合病院(東京都)、さいたま市立病院(埼玉県)、国立国際医療研究センター病院(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Prospective study |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000008913 |